CoChat
Sign Up
Cited by 193Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition

Open access
Rodriguez, Gustavo A, Tai, Leon M, LaDu, Mary Jo, Rebeck, G William·2014·Journal of Neuroinflammation
DOI 10.1186/1742-2094-11-111PMC PMC4077554
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Having the apolipoprotein E4 (APOE-ϵ4) allele is the strongest genetic risk factor for the development of Alzheimer's disease (AD). Accumulation of amyloid beta (Aβ) in the brain is influenced by APOE genotype. Transgenic mice co-expressing five familial AD mutations (5xFAD) in the presence of human APOE alleles (ϵ2, ϵ3 or ϵ4) exhibit APOE genotype-specific differences in early Aβ accumulation, suggesting an interaction between APOE and AD pathology. Whether APOE genotype affects Aβ-plaque-associated neuroinflammation remains unclear. In the current study, we address the role of APOE genotype on Aβ-associated microglial reactivity in the EFAD transgenic mouse model. METHODS: We analyzed Aβ-induced glial activation in the brains of 6-month-old EFAD transgenic mice (E2FAD, E3FAD and E4FAD). Region-specific morphological profiles of Aβ plaques in EFAD brain sections were compared using immunofluorescence staining. We then determined the degree of glial activation in sites of Aβ deposition while comparing levels of the inflammatory cytokine Interleukin-1β (IL-1β) by ELISA. Finally, we quantified parameters of Aβ-associated microglial reactivity using double-stained EFAD brain sections. RESULTS: Characterization of Aβ plaques revealed there were larger and more intensely stained plaques in E4FAD mice relative to E2FAD and E3FAD mice. E4FAD mice also had a greater percentage of compact plaques in the subiculum than E3FAD mice. Reactive microglia and dystrophic astrocytes were prominent in EFAD brains, and primarily localized to two sites of significant Aβ deposition: the subiculum and deep layers of the cortex. Cortical levels of IL-1β were nearly twofold greater in E4FAD mice relative to E3FAD mice. To control for differences in levels of Aβ in the different EFAD mice, we analyzed the microglia within domains of specific Aβ deposits. Morphometric analyses revealed increased measures of microglial reactivity in E4FAD mice, including greater dystrophy, increased fluorescence intensity and a higher density of reactive cells surrounding cortical plaques, than in E3FAD mice. CONCLUSIONS: In addition to altering morphological profiles of Aβ deposition, APOE genotype influences Aβ-induced glial activation in the adult EFAD cortex. These data support a role for APOE in modulating Aβ-induced neuroinflammatory responses in AD progression, and support the use of EFAD mice as a suitable model for mechanistic studies of Aβ-associated neuroinflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-11-111

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 APOE genotype affects Aβ plaque morphology in EFAD subiculum and deep layers of cortex. Morphologically distinct Aβ plaques were visualized in the subiculum and deep layers of the cortex of 6-month-old EFAD mice using immunofluorescence staining with Aβ antibody MOAB2. (A) Heterogeneous plaque types were evident in EFAD brains and grouped into three categories: diffuse, dense core and compact. Scale bar: 12 μm. (B) Subiculum. Left: E4FAD mice exhibited larger plaques on average than E3FAD mice. Center: Fluorescence intensity of plaques did not differ by APOE genotype. Right: E2FAD mice exhibited a greater percentage of diffuse plaques than E3FAD or E4FAD mice, and a lower percentage of dense core plaques than E3FAD mice. Interestingly, E4FAD mice exhibited an increased percentage of compact plaques in the subiculum. (C) Deep layers of the cortex. Left: Plaque size did not differ by APOE genotype. Center: Fluorescence intensity of deep cortical plaques was highest in E4FAD mice. Right: E2FAD mice had a greater percentage of diffuse plaques in this region than E4FAD mice. No differences were detected between APOE genotype for dense core or compact plaques. One-way ANOVA, * P < 0.05. Two-way ANOVA, * P < 0.05, ** P < 0.01.
Figure 1 APOE genotype affects Aβ plaque morphology in EFAD subiculum and deep layers of cortex. Morphologically distinct Aβ plaques were visualized in the subiculum and deep layers of the cortex of 6-month-old EFAD mice using immunofluorescence staining with Aβ antibody MOAB2. (A) Heterogeneous plaque types were evident in EFAD brains and grouped into three categories: diffuse, dense core and compact. Scale bar: 12 μm. (B) Subiculum. Left: E4FAD mice exhibited larger plaques on average than E3FAD mice. Center: Fluorescence intensity of plaques did not differ by APOE genotype. Right: E2FAD mice exhibited a greater percentage of diffuse plaques than E3FAD or E4FAD mice, and a lower percentage of dense core plaques than E3FAD mice. Interestingly, E4FAD mice exhibited an increased percentage of compact plaques in the subiculum. (C) Deep layers of the cortex. Left: Plaque size did not differ by APOE genotype. Center: Fluorescence intensity of deep cortical plaques was highest in E4FAD mice. Right: E2FAD mice had a greater percentage of diffuse plaques in this region than E4FAD mice. No differences were detected between APOE genotype for dense core or compact plaques. One-way ANOVA, * P < 0.05. Two-way ANOVA, * P < 0.05, ** P < 0.01.CC BY · PubMed Central
Figure 2 Glial activation is increased in the EFAD subiculum and cortex, while E4FAD mice exhibit elevated IL-1β levels. Astrocytes and microglia were visualized in sagittal brain sections of 6-month-old EFAD mice using immunohistochemistry. Initial DAB staining revealed prominent gliosis in two regions of the brain: the subiculum and deep layers of the cortex. (A) Extensive GFAP-immunoperoxidase staining was evident in the subiculum of all EFAD mice. In addition, dystrophic astrocytes could be seen throughout the deep layers, but not in superficial layers, of the EFAD cortex. Insets: 20× magnification of the subiculum (dashed red box). Magenta arrows: Clusters of dystrophic astrocytes in the cortex. Scale bar: 500 μm. (B) Activated microglial cells were clearly visible in the subiculum of all EFAD mice and were present in deep cortical layers as well. E4FAD sections exhibited more activated microglia in the deep cortex than E2FAD and E3FAD sections. Green arrows: Activated microglia. Scale bar: 500 μm. (C) Double immunofluorescence staining for GFAP (magenta) and Iba1 (green) confirmed region-specific glial activation in EFAD brains. Representative images of EFAD subicula are shown. Scale bar: 30 μm. (D) Levels of the pro-inflammatory cytokine IL-1β were measured using ELISA in 6-month-old EFAD cortex (CTX) extracts. E4FAD sections exhibited significantly higher levels of IL-1β than E3FAD sections. One-way ANOVA, ** P < 0.01.
Figure 2 Glial activation is increased in the EFAD subiculum and cortex, while E4FAD mice exhibit elevated IL-1β levels. Astrocytes and microglia were visualized in sagittal brain sections of 6-month-old EFAD mice using immunohistochemistry. Initial DAB staining revealed prominent gliosis in two regions of the brain: the subiculum and deep layers of the cortex. (A) Extensive GFAP-immunoperoxidase staining was evident in the subiculum of all EFAD mice. In addition, dystrophic astrocytes could be seen throughout the deep layers, but not in superficial layers, of the EFAD cortex. Insets: 20× magnification of the subiculum (dashed red box). Magenta arrows: Clusters of dystrophic astrocytes in the cortex. Scale bar: 500 μm. (B) Activated microglial cells were clearly visible in the subiculum of all EFAD mice and were present in deep cortical layers as well. E4FAD sections exhibited more activated microglia in the deep cortex than E2FAD and E3FAD sections. Green arrows: Activated microglia. Scale bar: 500 μm. (C) Double immunofluorescence staining for GFAP (magenta) and Iba1 (green) confirmed region-specific glial activation in EFAD brains. Representative images of EFAD subicula are shown. Scale bar: 30 μm. (D) Levels of the pro-inflammatory cytokine IL-1β were measured using ELISA in 6-month-old EFAD cortex (CTX) extracts. E4FAD sections exhibited significantly higher levels of IL-1β than E3FAD sections. One-way ANOVA, ** P < 0.01.CC BY · PubMed Central
Figure 3 Confocal microscopy analysis of Aβ-associated microglial activation in EFAD mice. Sagittal brain sections from 6-month-old EFAD mice were analyzed for Aβ deposition and associated microglial activation in two regions of interest, the subiculum and deep layers of the cortex. Reactive microglial cells within the vicinity of Aβ plaques consistently exhibited an amoeboid-like shape with dystrophic processes. (A) Two-dimensional projection image (approximately 20 μm, z-axis) of a E3FAD subiculum double stained for Aβ1–42 (MOAB2) and activated microglia (Iba1). Image overlays depict metrics used to characterize and quantify Aβ deposition and associated microglial activation. White arrows: Examples of plaque domains. (B) Grayscale image of Aβ plaques chosen for analysis. Plaque types, size of plaques and MOAB2 fluorescence intensity were quantified. Magenta: Traced plaques. (C) Grayscale image of activated microglia with plaque domain overlays. The number of microglia cell bodies within plaque domains were collected and quantified along with Iba1 fluorescence intensity. Yellow ring: Plaque domains (4.42 mm2). (D) Thresholding was performed within plaque domains to quantify the percentage area occupied by microglia cell bodies and processes. Representative minimum threshold value of 35 (0 to 255 brightness scale) depicted. Blue: Background. Scale bars: 20 μm.
Figure 3 Confocal microscopy analysis of Aβ-associated microglial activation in EFAD mice. Sagittal brain sections from 6-month-old EFAD mice were analyzed for Aβ deposition and associated microglial activation in two regions of interest, the subiculum and deep layers of the cortex. Reactive microglial cells within the vicinity of Aβ plaques consistently exhibited an amoeboid-like shape with dystrophic processes. (A) Two-dimensional projection image (approximately 20 μm, z-axis) of a E3FAD subiculum double stained for Aβ1–42 (MOAB2) and activated microglia (Iba1). Image overlays depict metrics used to characterize and quantify Aβ deposition and associated microglial activation. White arrows: Examples of plaque domains. (B) Grayscale image of Aβ plaques chosen for analysis. Plaque types, size of plaques and MOAB2 fluorescence intensity were quantified. Magenta: Traced plaques. (C) Grayscale image of activated microglia with plaque domain overlays. The number of microglia cell bodies within plaque domains were collected and quantified along with Iba1 fluorescence intensity. Yellow ring: Plaque domains (4.42 mm2). (D) Thresholding was performed within plaque domains to quantify the percentage area occupied by microglia cell bodies and processes. Representative minimum threshold value of 35 (0 to 255 brightness scale) depicted. Blue: Background. Scale bars: 20 μm.CC BY · PubMed Central
Figure 4 Aβ deposition in the subiculum is associated with high levels of microglial reactivity. Double immunofluorescence staining of 6-month-old EFAD subicula revealed significant Aβ deposition and elevated microglial activation in each group. (A) Representative images of fluorescence staining in EFAD subiculum. Aβ-associated microglial activation was assessed for each APOE genotype (n = 4 or 5 mice/APOE genotype). Scale bar: 30 μm. (B) Microglial density, fluorescence intensity and percentage area of the plaque domain did not differ between APOE genotypes. Within the subiculum, the reactive microglia in each group occupies a large percentage of the plaque domains relative to the deep cortex.
Figure 4 Aβ deposition in the subiculum is associated with high levels of microglial reactivity. Double immunofluorescence staining of 6-month-old EFAD subicula revealed significant Aβ deposition and elevated microglial activation in each group. (A) Representative images of fluorescence staining in EFAD subiculum. Aβ-associated microglial activation was assessed for each APOE genotype (n = 4 or 5 mice/APOE genotype). Scale bar: 30 μm. (B) Microglial density, fluorescence intensity and percentage area of the plaque domain did not differ between APOE genotypes. Within the subiculum, the reactive microglia in each group occupies a large percentage of the plaque domains relative to the deep cortex.CC BY · PubMed Central
Figure 5 APOE4 is associated with increased microglial reactivity to Aβ in deep layers of the cortex. Morphological profiles of reactive microglia within deep cortical Aβ plaque domains were elevated in E4FAD mice. (A) Representative double-stained images of Aβ plaques and microglial activation in deep layers of EFAD cortices (n = 4 or 5 mice/APOE genotype). Scale bar: 30 μm. (B) Left: E4FAD and E2FAD mice exhibited increased reactive microglial density within Aβ plaque domains. Center: Fluorescence intensity of the microglia was elevated in E4FAD mice relative to E3FAD mice. Right: E4FAD microglia occupied a larger percentage of plaque domains than E3FAD microglia. One-way ANOVA, * P < 0.05, ** P < 0.01.
Figure 5 APOE4 is associated with increased microglial reactivity to Aβ in deep layers of the cortex. Morphological profiles of reactive microglia within deep cortical Aβ plaque domains were elevated in E4FAD mice. (A) Representative double-stained images of Aβ plaques and microglial activation in deep layers of EFAD cortices (n = 4 or 5 mice/APOE genotype). Scale bar: 30 μm. (B) Left: E4FAD and E2FAD mice exhibited increased reactive microglial density within Aβ plaque domains. Center: Fluorescence intensity of the microglia was elevated in E4FAD mice relative to E3FAD mice. Right: E4FAD microglia occupied a larger percentage of plaque domains than E3FAD microglia. One-way ANOVA, * P < 0.05, ** P < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

Sorted by citations

Items 101–188 of 188

Related

See all

Metadata

Authors
Rodriguez, G. A., Tai, L. M., LaDu, M. J., & Rebeck, G. W.
Affiliations
  • Georgetown University Medical Center (US)
  • University of Illinois Chicago (US)
Corresponding author
Rebeck, G William
ORCID
Venue
Journal of Neuroinflammation
Publisher
Springer Science and Business Media LLC
Published
2014-06-19
Volume
11
Issue
1
Pages
111-111
ISSN
1742-2094 (ISSN-L)
DOI
10.1186/1742-2094-11-111
PMC
PMC4077554
OpenAlex
W2107281222
Cited by
193
References
67
Citations by year
2026: 11 · 2025: 15 · 2024: 19 · 2023: 20 · 2022: 28 · 2021: 19 · 2020: 21 · 2019: 13 · 2018: 14 · 2017: 12 · 2016: 5 · 2015: 15 · 2014: 1
FWCI
7.33
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000050)
  • University of Illinois at Urbana-Champaign (UL1TR000050)
  • University of Illinois at Chicago (UL1TR000050)
  • National Institute on Aging (P01AG030128, R01AG035379, R01 AG035379-S)
  • National Institute of Neurological Disorders and Stroke (T32 NS041218-S1, T32NS041218)
  • National Center for Advancing Translational Sciences
  • Office of the Vice Chancellor for Research, University of Illinois at Chicago
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
APOE ε4, apolipoprotein E, Alzheimer's disease, amyloid plaques, microglial activation, neuroinflammation, 5xFAD mice, IL-1β, APOE genotype, plaque morphology, subiculum, glial activation, APOE ε3
MeSH terms
Alzheimer Disease, Animals, Cerebral Cortex, Disease Models, Animal, Gene Expression Regulation, Humans, Mice, Transgenic, Mutation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Microscopy, Confocal, Mice, Apolipoprotein E4, Interleukin-1beta, Presenilin-1, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review